Express Scripts drops coverage of Valeant diabetes drug Glumetza
January 29, 2016 at 15:45 PM EST
NEW YORK, Jan 29 (Reuters) - Express Scripts Holding Co , the U.S. No. 1 pharmacy benefits manager, said on Friday it would stop covering Glumetza, a diabetes drug made by Valeant Pharmaceuticals International Inc, after a generic competitor enters the market on Feb. 1.